Global Advanced Drug Delivery Systems Market 2022-2026
Technavio has been monitoring the advanced drug delivery systems market and it is poised to grow by $ 91.79 bn during 2022-2026 decelerating at a CAGR of 7.41% during the forecast period. Our report on advanced drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising chronic diseases and rising investment in research and development of drug delivery.
The advanced drug delivery systems market analysis includes the type segment and geographic landscape.
Technavio's advanced drug delivery systems market is segmented as below:
By Type
- Oral
- Injection and inhalation
- Transdermal
- Carrier-based
- Others
- North America
- Europe
- Asia
- ROW
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on advanced drug delivery systems market covers the following areas:
- Advanced drug delivery systems market sizing
- Advanced drug delivery systems market forecast
- Advanced drug delivery systems market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Companies Mentioned
3M Co., Alkermes Public Co. Ltd., Antares Pharma Inc., Baxter International Inc., Becton Dickinson and Co., Endo International Plc, NanoPass Technologies Ltd., Nektar Therapeutics, Perrigo Co. Plc, Teva Pharmaceutical Industries Ltd.
- Executive Summary
- Market Landscape
- Market ecosystem
- Parent Market
- Table Parent market
- Table Market characteristics
- Parent Market
- Value chain analysis
- Table Value chain analysis: Life Sciences Tools and Services
- Research and development
- Inputs
- Production
- Distribution
- Marketing and sales
- Post-sales and services
- Market ecosystem
- Market Sizing
- Market definition
- Table Offerings of vendors included in the market definition
- Market segment analysis
- Table Market segments
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
- Estimating growth rates for emerging and high-growth markets
- Estimating growth rates for mature markets
- Table Global - Market size and forecast 2021 - 2026 ($ billion)
- Table Global market: Year-over-year growth 2021 - 2026 (%)
- Market definition
- Five Forces Analysis
- Five forces summary
- Table Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Table Bargaining power of buyers
- Bargaining power of suppliers
- Table Bargaining power of suppliers
- Threat of new entrants
- Table Threat of new entrants
- Threat of substitutes
- Table Threat of substitutes
- Threat of rivalry
- Table Threat of rivalry
- Market condition
- Table Market condition - Five forces 2021
- Five forces summary
- Market Segmentation by Type
- Market segments
- Table Type - Market share 2021-2026 (%)
- Comparison by Type
- Table Comparison by Type
- Oral - Market size and forecast 2021-2026
- Table Oral - Market size and forecast 2021-2026 ($ billion)
- Table Oral - Year-over-year growth 2021-2026 (%)
- Injection and inhalation - Market size and forecast 2021- 2026
- Table Injection and inhalation - Market size and forecast 2021-2026 ($ billion)
- Table Injection and inhalation - Year-over-year growth 2021-2026 (%)
- Transdermal - Market size and forecast 2021-2026
- Table Transdermal - Market size and forecast 2021-2026 ($ billion)
- Table Transdermal - Year-over-year growth 2021-2026 (%)
- Carrier-based - Market size and forecast 2021-2026
- Table Carrier-based - Market size and forecast 2021-2026 ($ billion)
- Table Carrier-based - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026
- Table Others - Market size and forecast 2021-2026 ($ billion)
- Table Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by Type
- Table Market opportunity by Type
- Market segments
- Customer Landscape
- Table Customer landscape
- Geographic Landscape
- Geographic segmentation
- Table Market share by geography 2021-2026 (%)
- Geographic comparison
- Table Geographic comparison
- North America - Market size and forecast 2021-2026
- Table North America - Market size and forecast 2021-2026 ($ billion)
- Table North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026
- Table Europe - Market size and forecast 2021-2026 ($ billion)
- Table Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026
- Table Asia - Market size and forecast 2021-2026 ($ billion)
- Table Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026
- Table ROW - Market size and forecast 2021-2026 ($ billion)
- Table ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Table Key leading countries
- Market opportunity by geography
- Table Market opportunity by geography ($ billion)
- Geographic segmentation
- Drivers, Challenges, and Trends
- Market drivers
- Rising chronic diseases
- Rising investment in research and development of drug delivery
- Market challenges
- Presence of stringent regulations
- Poor healthcare infrastructure in underdeveloped or developing countries
- Table Impact of drivers and challenges
- Market trends
- Covid-19 pandemic to create multiple opportunities in the market
- Introduction of targeted drug delivery system
- Market drivers
- Vendor Landscape
- Table Vendor landscape
- Landscape disruption
- Table Landscape disruption
- Table Industry risks
- Competitive scenario
- Vendor Analysis
- Vendors covered
- Table Vendors covered
- Market positioning of vendors
- Table Market positioning of vendors
- 3M Co.
- Table 3M Co. - Overview
- Table 3M Co. - Business segments
- Table 3M Co. - Key offerings
- Table 3M Co. - Segment focus
- Alkermes Public Co. Ltd.
- Table Alkermes Public Co. Ltd. - Overview
- Table Alkermes Public Co. Ltd. - Business segments
- Table Alkermes Public Co. Ltd. - Key news
- Table Alkermes Public Co. Ltd. - Key offerings
- Antares Pharma Inc.
- Table Antares Pharma Inc. - Overview
- Table Antares Pharma Inc. - Business segments
- Table Antares Pharma Inc. - Key news
- Table Antares Pharma Inc. - Key offerings
- Baxter International Inc.
- Table Baxter International Inc. - Overview
- Table Baxter International Inc. - Business segments
- Table Baxter International Inc. - Key offerings
- Table Baxter International Inc. - Segment focus
- Becton Dickinson and Co.
- Table Becton Dickinson and Co. - Overview
- Table Becton Dickinson and Co. - Business segments
- Table Becton Dickinson and Co. - Key offerings
- Table Becton Dickinson and Co. - Segment focus
- Endo International Plc
- Table Endo International Plc - Overview
- Table Endo International Plc - Business segments
- Table Endo International Plc. - Key news
- Table Endo International Plc - Key offerings
- Table Endo International Plc - Segment focus
- NanoPass Technologies Ltd.
- Table NanoPass Technologies Ltd. - Overview
- Table NanoPass Technologies Ltd. - Product and service
- Table NanoPass Technologies Ltd. - Key offerings
- Nektar Therapeutics
- Table Nektar Therapeutics - Overview
- Table Nektar Therapeutics - Product and service
- Table Nektar Therapeutics - Key offerings
- Perrigo Co. Plc
- Table Perrigo Co. Plc - Overview
- Table Perrigo Co. Plc - Business segments
- Table Perrigo Co. Plc - Key offerings
- Table Perrigo Co. Plc - Segment focus
- Teva Pharmaceutical Industries Ltd.
- Table Teva Pharmaceutical Industries Ltd. - Overview
- Table Teva Pharmaceutical Industries Ltd. - Business segments
- Table Teva Pharmaceutical Industries Ltd. - Key offerings
- Table Teva Pharmaceutical Industries Ltd. - Segment focus
- Vendors covered
- Appendix
- Scope of the report
- Market definition
- Objective
- Notes and caveats
- Currency conversion rates for US$
- Table Currency conversion rates for US$
- Research methodology
- Table Research Methodology
- Table Validation techniques employed for market sizing
- Table Information sources
- List of abbreviations
- Table List of abbreviations
- Scope of the report
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook